EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pre-transplant Anemia as a Marker of Short-term Outcomes in Lung Transplant Recipients

Anil J Trindade, Avery K Fortier, William D Tucker, Abigail K Martel, Whitney D Gannon, Matthew Bacchetta

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.06.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Anil J Trindade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Medical Center North, Nashvi…. Hauptthemen laut MEDLINE: Lung Transplantation, Anemia, Biomarkers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anemia is a risk factor for increased morbidity and mortality in multiple medical conditions, yet the impact of pretransplant anemia in patients with advanced lung disease on post-transplant outcomes remains under-explored. We sought to determine whether pretransplant anemia serves as a marker of altered inflammation in the host and associates with short-term outcomes following lung transplantation. STUDY DESIGN AND METHODS: We performed a single-center, retrospective analysis of 238 lung transplant recipients. We assessed for risk factors of pretransplant anemia and identified associations with short-term post-transplant outcomes. RESULTS: Pretransplant anemia was associated with increased intraoperative transfusion of packed red blood cells and a trend towards increased index hospital length of stay and 1-year mortality. Conversely, pretransplant anemia was associated with a decreased incidence of acute cellular rejection. CONCLUSION: These preliminary data suggest that anemia may be a biomarker of altered inflammation in the host recipient and influences post-transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationAnemiaBiomarkersHumansRetrospective StudiesFemaleMaleMiddle AgedRisk FactorsTreatment OutcomeAdultGraft RejectionLength of StayAged

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee; Vanderbilt Transplant Center, Vanderbilt University Me…
  • Vanderbilt University, Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee.
  • Department of Cardiac Surgery, Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee.
  • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee.
  • Department of Cardiac Surgery, Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee; Department of Biomedical Engineering, Vanderbilt University Medical Center, Medical Center North, Nashvill…

Zitieren

APA

Trindade, A. J., Fortier, A. K., Tucker, W. D., Martel, A. K., Gannon, W. D., & Bacchetta, M. (2024). Pre-transplant Anemia as a Marker of Short-term Outcomes in Lung Transplant Recipients. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.06.007

Vancouver

Trindade AJ, Fortier AK, Tucker WD, Martel AK, Gannon WD, Bacchetta M. Pre-transplant Anemia as a Marker of Short-term Outcomes in Lung Transplant Recipients. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.06.007

BibTeX
@article{Trindade2024,
  author = {Trindade, Anil J and Fortier, Avery K and Tucker, William D and Martel, Abigail K and Gannon, Whitney D and Bacchetta, Matthew},
  title = {Pre-transplant Anemia as a Marker of Short-term Outcomes in Lung Transplant Recipients},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.06.007}
}
Kostenlos starten →